Screening Visit
chronic pulmonary disease, peripheral lymphedema
CHRONIC PULMONARY DISEASE, GLOMERULONEPHRITIS
At the baseline visit (T0), the eligible patients underwent a clinical and laboratory screening assessment and were considered suitable for intervention if presented pre-transplant panel reactive antibodies <50%, no donor specific antibodies anytime, no history of chronic pulmonary disease, no peripheral lymphedema, no post-transplant glomerulonephritis, estimated glomerular filtration rate ≥ 40 mL/min/1.73m